Literature DB >> 32108395

The X-linked filaminopathies: Synergistic insights from clinical and molecular analysis.

Emma M Wade1, Benjamin J Halliday1, Zandra A Jenkins1, Adam C O'Neill1, Stephen P Robertson1.   

Abstract

The X-linked filaminopathies represent a diverse group of clinical conditions, all caused by variants in the gene FLNA. FLNA encodes the widely expressed actin binding protein, filamin A that has multiple roles during embryonic development including cell migration, mechanical sensing, and cell signaling. In this review, we discuss the 10 distinct X-linked filaminopathy conditions that between them affect almost all organ systems, including the brain, skeleton, heart, and skin, highlighting the critical role of this protein in human development. We review each of the phenotypes and discuss their pathogenesis, where known. Assigning pathogenicity to variants in FLNA can prove difficult, especially for missense variants and small indels, in-part because of the X-linked nature of the phenotypes, the overlap of phenotypic features between conditions, and poor understanding of the function of certain protein domains. We outline here approaches to characterize phenotypes, highlight hotspot regions within FLNA commonly mutated in these conditions, and approaches to resolving some variants of uncertain significance.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  X-linked disease; filamin A; filaminopathy; periventricular nodular heterotopia; skeletal dysplasia

Mesh:

Substances:

Year:  2020        PMID: 32108395     DOI: 10.1002/humu.24002

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  FLN-1/filamin is required to anchor the actomyosin cytoskeleton and for global organization of sub-cellular organelles in a contractile tissue.

Authors:  Charlotte A Kelley; Olivia Triplett; Samyukta Mallick; Kristopher Burkewitz; William B Mair; Erin J Cram
Journal:  Cytoskeleton (Hoboken)       Date:  2020-10-08

2.  Heterogeneous Pulmonary Phenotypes in Filamin A Mutation-Related Lung Disease.

Authors:  Amit S Shah; Emily D Black; Dawn M Simon; Michael J Gambello; Kathryn B Garber; Glen J Iannucci; Erica L Riedesel; Ajay S Kasi
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2021-03       Impact factor: 1.349

Review 3.  Molecular Tuning of Filamin A Activities in the Context of Adhesion and Migration.

Authors:  Isabelle Lamsoul; Loïc Dupré; Pierre G Lutz
Journal:  Front Cell Dev Biol       Date:  2020-11-20

4.  Filamin A Orchestrates Cytoskeletal Structure, Cell Migration and Stem Cell Characteristics in Human Seminoma TCam-2 Cells.

Authors:  Harald Welter; Carola Herrmann; Thomas Fröhlich; Florian Flenkenthaler; Katja Eubler; Hubert Schorle; Daniel Nettersheim; Artur Mayerhofer; Annette Müller-Taubenberger
Journal:  Cells       Date:  2020-11-30       Impact factor: 6.600

Review 5.  β2 Integrin Signaling Cascade in Neutrophils: More Than a Single Function.

Authors:  Panagiota Bouti; Steven D S Webbers; Susanna C Fagerholm; Ronen Alon; Markus Moser; Hanke L Matlung; Taco W Kuijpers
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

6.  Hemizygous FLNA variant in West syndrome without periventricular nodular heterotopia.

Authors:  Yoshitaka Hiromoto; Yoshiteru Azuma; Yuichi Suzuki; Megumi Hoshina; Yuri Uchiyama; Satomi Mitsuhashi; Satoko Miyatake; Takeshi Mizuguchi; Atsushi Takata; Noriko Miyake; Mitsuhiro Kato; Naomichi Matsumoto
Journal:  Hum Genome Var       Date:  2020-12-03

7.  Platelet function and filamin A expression in two families with novel FLNA gene mutations associated with periventricular nodular heterotopia and panlobular emphysema.

Authors:  Laura M Tanner; Shinji Kunishima; Elina Lehtinen; Tuukka Helin; Kirsi Volmonen; Riitta Lassila; Minna Pöyhönen
Journal:  Am J Med Genet A       Date:  2022-02-14       Impact factor: 2.578

8.  Case Report: Pansynostosis, Chiari I Malformation and Syringomyelia in a Child With Frontometaphyseal Dysplasia 1.

Authors:  Jaewon Kim; Dong-Woo Lee; Dae-Hyun Jang
Journal:  Front Pediatr       Date:  2021-07-01       Impact factor: 3.418

9.  Terminal osseous dysplasia with pigmentary defects and cardiomyopathy caused by a novel FLNA variant.

Authors:  Lynne Rumping; Marja W Wessels; Alex V Postma; Joost van Schuppen; Marjon A van Slegtenhorst; Jasper J Saris; J Peter van Tintelen; Stephen P Robertson; Mariëlle Alders; Saskia M Maas; Ronald H Lekanne Deprez
Journal:  Am J Med Genet A       Date:  2021-07-13       Impact factor: 2.578

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.